Dhruva SS - Search Results

1

Use of Electronic Health Records to Characterize Patients with Uncontrolled Hypertension in Two Large Health System Networks.

Lu Y, Keeley EC, Barrette E, Cooper-DeHoff RM, Dhruva SS, Gaffney J, Gamble G, Handke B, Huang C, Krumholz HM, McDonough Rowe CW, Schulz W, Shaw K, Smith M, Woodard J, Young P, Ervin K, Ross JS. Lu Y, et al. Among authors: dhruva ss. medRxiv [Preprint]. 2023 Jul 28:2023.07.26.23293225. doi: 10.1101/2023.07.26.23293225. medRxiv. 2023. PMID: 37546792 Free PMC article. Preprint.

2

Revisiting Essure--Toward Safe and Effective Sterilization.

Dhruva SS, Ross JS, Gariepy AM. Dhruva SS, et al. N Engl J Med. 2015 Oct 8;373(15):e17. doi: 10.1056/NEJMp1510514. Epub 2015 Sep 23. N Engl J Med. 2015. PMID: 26397951 No abstract available.

3

The Core Value of Cost-Effectiveness Analyses.

Dhruva SS, Krumholz HM. Dhruva SS, et al. J Am Coll Cardiol. 2016 Jan 5;67(1):39-41. doi: 10.1016/j.jacc.2015.11.013. J Am Coll Cardiol. 2016. PMID: 26764064 Free PMC article. No abstract available.

4

Championing Effectiveness Before Cost-Effectiveness.

Dhruva SS, Krumholz HM. Dhruva SS, et al. JACC Heart Fail. 2016 May;4(5):376-9. doi: 10.1016/j.jchf.2016.02.001. Epub 2016 Mar 30. JACC Heart Fail. 2016. PMID: 27039130 Free PMC article. No abstract available.

5

Real-World Data on Heart Failure Readmission Reduction: Real or Real Uncertain?

Krumholz HM, Dhruva SS. Krumholz HM, et al. Among authors: dhruva ss. J Am Coll Cardiol. 2017 May 16;69(19):2366-2368. doi: 10.1016/j.jacc.2017.03.019. Epub 2017 Mar 19. J Am Coll Cardiol. 2017. PMID: 28330750 Free article. No abstract available.

6

Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).

Dhruva SS, Huang C, Spatz ES, Coppi AC, Warner F, Li SX, Lin H, Xu X, Furberg CD, Davis BR, Pressel SL, Coifman RR, Krumholz HM. Dhruva SS, et al. Hypertension. 2017 Jul;70(1):94-102. doi: 10.1161/HYPERTENSIONAHA.117.09221. Epub 2017 May 30. Hypertension. 2017. PMID: 28559399 Clinical Trial.

7

Inclusion of Demographic-Specific Information in Studies Supporting US Food & Drug Administration Approval of High-Risk Medical Devices.

Dhruva SS, Mazure CM, Ross JS, Redberg RF. Dhruva SS, et al. JAMA Intern Med. 2017 Sep 1;177(9):1390-1391. doi: 10.1001/jamainternmed.2017.3148. JAMA Intern Med. 2017. PMID: 28738116 Free PMC article.

8

The FDA Unapproved Drugs Initiative: An Observational Study of the Consequences for Drug Prices and Shortages in the United States.

Gupta R, Dhruva SS, Fox ER, Ross JS. Gupta R, et al. Among authors: dhruva ss. J Manag Care Spec Pharm. 2017 Oct;23(10):1066-1076. doi: 10.18553/jmcp.2017.23.10.1066. J Manag Care Spec Pharm. 2017. PMID: 28944731 Free PMC article.

9

Merits of Data Sharing: The Digitalis Investigation Group Trial.

Angraal S, Ross JS, Dhruva SS, Desai NR, Welsh JW, Krumholz HM. Angraal S, et al. Among authors: dhruva ss. J Am Coll Cardiol. 2017 Oct 3;70(14):1825-1827. doi: 10.1016/j.jacc.2017.07.786. J Am Coll Cardiol. 2017. PMID: 28958337 Free article. No abstract available.

10

Medicare Formulary Coverage Restrictions for Prescription Opioids, 2006 to 2015.

Samuels EA, Ross JS, Dhruva SS. Samuels EA, et al. Among authors: dhruva ss. Ann Intern Med. 2017 Dec 19;167(12):895-896. doi: 10.7326/M17-1823. Epub 2017 Oct 10. Ann Intern Med. 2017. PMID: 29052693 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page